Literature DB >> 3346101

Absence of expression of a human endogenous retrovirus is correlated with choriocarcinoma.

N Kato1, E Larsson, M Cohen.   

Abstract

We examined the RNA expression of a human endogenous provirus, termed ERV3, in 170 human tissue and cell specimens. The highest expression was found in normal placental chorionic villi as mRNAs of 9, 7.3, and 3.5 kb. The 7.3-kb RNA species was found only in the placenta. ERV3 mRNA was expressed in most other normal and malignant tissues at a level which was 2-10% of that seen in placenta. However, several tissues and tumor cell lines had higher transcriptional levels, equal to 10-60% of the placental level. In contrast, an almost complete abrogation of ERV3 mRNA expression was noted in choriocarcinoma cell lines and in an invasive hydatidiform mole tissue biopsy. This abrogation was not linked to deletions or rearrangements of the ERV3 genome. It appeared to be unassociated with methylation because the ERV3 provirus was similarly methylated in the DNA of placental chorionic villi and choriocarcinoma cells, and ERV3 transcription in choriocarcinoma cells was not induced by 5-azacytidine. These results suggest that the loss of ERV3 mRNA expression is associated with susceptibility to choriocarcinoma.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3346101     DOI: 10.1002/ijc.2910410310

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

1.  Physiological knockout of the envelope gene of the single-copy ERV-3 human endogenous retrovirus in a fraction of the Caucasian population.

Authors:  N de Parseval; T Heidmann
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

2.  ERV3 and related sequences in humans: structure and RNA expression.

Authors:  Ann-Catrin Andersson; Zhihong Yun; Göran O Sperber; Erik Larsson; Jonas Blomberg
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

3.  Human proviral mRNAs down regulated in choriocarcinoma encode a zinc finger protein related to Krüppel.

Authors:  N Kato; K Shimotohno; D VanLeeuwen; M Cohen
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

4.  Isolation and characterization of a family of rat endogenous retroviral sequences.

Authors:  M Nakamuta; M Furuich; K Takahashi; N Suzuki; H Endo; M Yamamoto
Journal:  Virus Genes       Date:  1989-09       Impact factor: 2.332

5.  Distribution of retroviral p15E-related proteins in neoplastic and non-neoplastic human tissues, and their role in the regulation of the immune response.

Authors:  R A Scheeren; R A Oostendorp; S van der Baan; R M Keehnen; R J Scheper; C J Meijer
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

6.  Molecular characterization and placental expression of HERV-W, a new human endogenous retrovirus family.

Authors:  J L Blond; F Besème; L Duret; O Bouton; F Bedin; H Perron; B Mandrand; F Mallet
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

7.  Splicing of a human endogenous retrovirus to a novel phospholipase A2 related gene.

Authors:  A E Feuchter-Murthy; J D Freeman; D L Mager
Journal:  Nucleic Acids Res       Date:  1993-01-11       Impact factor: 16.971

8.  Detection of the human endogenous retrovirus ERV3-encoded Env-protein in human tissues using antibody-based proteomics.

Authors:  Chen Fei; Christina Atterby; Per-Henrik Edqvist; Fredrik Pontén; Wei Wei Zhang; Erik Larsson; Frank P Ryan
Journal:  J R Soc Med       Date:  2013-11-21       Impact factor: 5.344

9.  Expression of endogenous retroviruses, ERV3 and lambda 4-1, in synovial tissues from patients with rheumatoid arthritis.

Authors:  K Takeuchi; K Katsumata; H Ikeda; M Minami; A Wakisaka; T Yoshiki
Journal:  Clin Exp Immunol       Date:  1995-03       Impact factor: 4.330

Review 10.  Endogenous Retrovirus 3 - History, Physiology, and Pathology.

Authors:  Yomara Y Bustamante Rivera; Christine Brütting; Caroline Schmidt; Ines Volkmer; Martin S Staege
Journal:  Front Microbiol       Date:  2018-01-15       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.